Talk:Asfotase alfa
Appearance
This is the talk page for discussing improvements to the Asfotase alfa article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
It is of interest to the following WikiProjects:
This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks. | ||
Mid | This article has been rated as Mid-importance on the project's importance scale. |
WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine. | This article is within the scope of||
Mid | This article has been rated as Mid-importance on the project's importance scale. |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Asfotase alfa.
|
Is it really necessary to include the peptide sequence?
[edit]I think it's too technical a piece of information for a general-purpose article. Cheers, --CopperKettle (talk) 14:51, 1 January 2023 (UTC)